Thomas Leggett - Chief Financial Officer at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
STOK on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Leggett since 09 Mar 2025

Holdings reported by Thomas Leggett for Stoke Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 40,000 $487,930 $8.27 17 Feb 2026 Direct Common Stock
Employee Stock Option (Right to Buy) 60,000 17 Feb 2026 Direct Common Stock

Transactions reported by Thomas Leggett for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.